Insmed, Inc. (INSM)
149.86
-1.17
(-0.77%)
USD |
NASDAQ |
Feb 06, 16:00
149.01
-0.85
(-0.57%)
After-Hours: 20:00
Insmed Shareholders Equity (Quarterly) : 945.57M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Biogen, Inc. | 18.26B |
| CorMedix, Inc. | 374.13M |
| Merck & Co., Inc. | -- |
| Pfizer Inc. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.361B |
| Total Liabilities (Quarterly) | 1.415B |
| Debt to Equity Ratio | 0.788 |
| Current Ratio | 4.630 |
| Net Debt Paydown Yield | 0.41% |